Billwin Indust. (543209)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 44.17% indicates expanding demand for the business.
• ROCE is positive at 9.09%, showing the existing capital base earns some return.
• Small market cap of ₹17 crore leaves room for meaningful growth if execution improves.
• P/E of 18.95 is not extreme if earnings can stabilize and recover.

Concerns

• Latest quarter net profit is ₹0 crore, while annual profit has declined 28.89%.
• Piotroski F-score of 4/9 points to weak overall financial health.
• No dividend is paid, so minority shareholders receive no cash return.
• Critical data like book value, ROE, and promoter holding are missing; the PEG ratio is misleading because it relies on sales growth, not profit growth.

AI Analysis

At first glance Billwin looks like a small, growing diversified business: sales up 44.17%, price near high. But my rule is never ignore the profit. Latest quarter net profit is ₹0 crore; annual profit has declined 28.89%. A company that cannot convert revenue growth into earnings is not compounding. With market cap ₹17 crore, P/E 18.95 implies earnings roughly ₹0.9 crore, so the market is paying ~19 times for a shrinking profit stream. ROCE of 9.09% is mediocre; my benchmark is at least a comfortable return over capital. F-score 4/9 reinforces my caution: seven signals would make me comfortable; four is weak. I cannot compute book value, ROE or promoter holding, and Graham would not buy what he cannot measure. The PEG of 0.43 is a trap: it uses 44% growth, but sales growth without profit growth is not value creation. There is no dividend, so minority shareholders wait for management to redeploy capital. The 52-week range of ₹22.50 to ₹42.80 shows high volatility; at ₹41 we are near the top. This is a speculative micro-cap, not a predictable franchise. No brand, no pricing power, no moat is evident from the disclosed data. I need to see profits stabilize and grow, cash flow, and better capital allocation before I can call it an investment. As Graham said, price is what you pay, value is what you get. Here, I don't know the value, and the earnings do not justify the price. For me, this is a pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer